11 jan: Indre værdi af SmallCap Danmark A/S er opgjort til 84,0 kr. pr. a..
11 jan: Danish Crown køber tysk slagteri
11.01.2017 07:59:53

Interim report Q1 - 1 September 2016 - 30 November 2016

Relateret indhold
16 aug - 
Onsdagens aktier: Beskedent fald til C20 efter stribe a..
03 aug - 
Aktier/middag: Et par C20'ere på rekordkurs i ellers sl..
02 aug - 
Aktier/middag: C20 løftes af rekorder i DSV og Chr. Han..
Relateret debat
05 jul - 
Du kan gå tilbage til første dag jeg var på EI. Jeg har..
05 jul - 
HAHA Så backtrader du igen
05 jul - 
Hvormeget af dagens kursstigning mon er eufori. Tror de..

Hoersholm, 2017-01-11 07:59 CET (GLOBE NEWSWIRE) --

 

Strong organic revenue growth of 11% in Q1 2016/17: Food Cultures & Enzymes (10%), Health & Nutrition (8%) and Natural Colors (13%). EBIT before special items increased by 21% to EUR 66 million.

 

EUR million

Q1

2016/17

Q1

2015/16

Growth

 

 

 

 

Revenue

  241.7

  214.4

13%

EBIT before special items

 65.5

54.0

21%

Profit for the period

47.0

 38.9

21%

Free cash flow before acquisitions, divestments and special items

  (19.1)

  (16.6)

(15)%

 

 

 

 

Organic growth, %

11%

14%

 

Gross margin, %

53.4%

52.3%

 

EBIT margin before special items, %

27.1%

25.2%

 

ROIC excl. goodwill, %

34.3%

33.1%

 

 

“The results in Q1 gave us a good start to the year, and we maintain our guidance for the full year. Both Food Cultures & Enzymes and Natural Colors delivered strong organic growth and improved profitability. The organic growth in Health & Nutrition was still below our long-term ambitions, however, better than expected for the quarter, mainly due to timing of orders. The EBIT margin for the business area was down, partly due to an unfavorable product mix,” says CEO Cees de Jong.

“We made good progress on our focus areas for 2016/17. Our bioprotective cultures continue to deliver strong growth. In Q1, growth was approximately 25%, and the segment now accounts for approximately 5% of the revenue in Food Cultures & Enzymes. In November, we concluded the acquisition of LGG®, and we have initiated integrating the business into Chr. Hansen. The integration of NPC is being concluded and we are starting to reap the synergies from the acquisition. Plant health supported the growth in Health & Nutrition with sales of both Nemix® C and VGR™, and we are making progress in our work to introduce new products in the coming years. Natural Colors showed good progress in Q1.”

 

OUTLOOK FOR 2016/17                                                                   

The outlook for 2016/17 is unchanged compared to the announcement of 26 October 2016.

Organic revenue growth: 8-10% (previously 8-10%)

EBIT margin before special items: slightly increasing (previously slightly increasing)

Free cash flow before acquisitions, divestments and special items:

around EUR 175 million (previously around EUR 175 million)

 

This unaudited interim report has been prepared in accordance with IAS 34 and additional Danish regulations. The interim report has been prepared in accordance with the accounting policies set out in the Annual Report for 2015/16.

 

For further information, please contact:

Cees de Jong, CEO

Tel: +45 4574 7474

Søren Westh Lonning, CFO

Tel: +45 4574 7474

Anders Mohr Christensen, Senior Director, Investor Relations

Tel: +45 4574 7618

 

Forward-looking statements

This announcement contains forward-looking statements. Such statements are subject to risks and uncertainties, as various factors, many of which are beyond the control of Chr. Hansen Holding A/S, may cause actual developments and results to differ materially from the expectations expressed in this announcement.

 

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2015/16 financial year was EUR 949 million. The company has more than 2,700 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen A/S. For further information, please visit www.chr-hansen.com.

Vedhæftet fil: Company announcement Q1.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Dong vil opføre vedligeholdelsesanlæg til kæmpe havmøllepark

18-08-2017 16:21:48
Dong Energy har underskrevet en hensigtserklæring med Zeeland Seaports om opførelse af et drifts- og vedligeholdelsesanlæg (O&M) i Vissingen Buitenhaven i det sydvestlige Holland, der skal servicere havmølleparkerne Borssele 1 og 2.Det oplyser selskabet i en meddelelse fredag eftermiddag.Der vil efter planen blive underskrevet en endelig aftale, når et område af havnen er blevet videreudviklet "he..

Siemens Gamesa afskediger 600 medarbejdere på vingefabrik i Aalborg

18-08-2017 14:30:08
Vindmølleproducenten Siemens Gamesa Renewable Energy foretager en kraftig reduktion i arbejdsstyrken på sin vingefabrik i Aalborg, hvilket sker som reaktion på ændrede markedsforhold og intensiveret konkurrence.I alt vil 730 medarbejdere på fabrikken, som i dag har 2100 ansatte, blive berørt, idet 600 ventes afskediget per 30. september 2017, mens 130 vil blive omplaceret på fabrikken.Det oplyser ..

Aktier/åbning: Novo tager bundplacering i rødt marked

18-08-2017 09:18:37
Det danske C20 Cap-indeks fortsætter de negative tendenser fra USA og Asien og åbner med et fald på 0,6 pct. i et overvejende rødt marked, hvor særligt Novo Nordisk skiller sig negativt ud.Eliteindekset følger altså uroen fra de tre store amerikanske aktieindeks, Dow Jones, S&P 500 og Nasdaq, som torsdag dykkede markant for anden gang på tre dage, samt de asiatiske markeder, der ligeledes overveje..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

Chr Hansen Holding A/S 524,50 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
20. august 2017 19:22:07
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170808.1 - EUROWEB2 - 2017-08-20 19:22:07 - 2017-08-20 19:22:07 - 1 - Website: OKAY